Charles River Labs Intl buy The Goldman Sachs Group, Inc.
Start price
23.01.25
/
50%
€159.40
Target price
23.01.26
€182.70
Performance (%)
5.80%
Price
15.12.25
€168.65
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr shows slight gains of 5.80%. This prediction currently runs until 23.01.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Charles River Labs Intl | 3.918% | 3.918% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $220.00 to $190.00. They now have a "buy" rating on the stock.
Ratings data for CRL provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€199.65
06.06.24
06.06.24
€266.42
06.06.25
06.06.25
-36.41%
07.06.25
07.06.25
